Computer Guided Versus Conventional TMJ Injection

March 18, 2022 updated by: AbdElKader Ahmed Hyder Mohamed, Al-Azhar University

Efficacy of Computer-guided Versus Conventional Sodium Hyaluronate Injection in Superior Joint Space in Treatment of Intra-articular TMJ Disorder

This study is designed to evaluate the clinical outcomes of computer-guided sodium hyaluronate injection in superior joint space in comparison to conventional injection for treatment of intra-articular TMJ disorder.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study aimed to reveal the superiority of computer-guided TMJ injection (if found) above the conventional method from the clinician and patient point of view.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11884
        • Faculty of Dentistry, Al-Azhar University.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients diagnosed with intra-articular TMJ disorder according to Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD).
  • Patients who would not respond to conservative treatment as the first line of treatment.

Exclusion Criteria:

  • Patients with polyarthritis or degenerative joint disease.
  • Patients with myofascial pain.
  • Previous history of minimally invasive or invasive treatment of TMJ.
  • History of mandibular fracture.
  • Lactating, pregnant or planning pregnancy women.
  • Known hypersensitivity to hyaluronic acid or clear biocompatible photopolymer resin.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
Patients treated with four computer-guided sodium hyaluronate injections in superior TMJ space.
four sodium hyaluronate injections in superior TMJ space
Active Comparator: Group B
Patients treated with four conventional sodium hyaluronate injections in superior TMJ space.
four sodium hyaluronate injections in superior TMJ space

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of maximum unassisted mouth opening range
Time Frame: 6 months
Opening range determined by asking the patient to gently open the mouth and measure the distance between upper and lower central incisor using an vernier digital electronic caliper. Vertical movement of the mandible corrected by adding the vertical overlap.
6 months
Comparison of modified Helkimo's clinical dysfunction index.
Time Frame: 6 months
A modified version of Helkimo's clinical dysfunction index calculated to assess the TMJ dysfunction.
6 months
Comparison of pain intensity on Visual analog scale
Time Frame: 6 months
Patients asked to mark their TMJ-related pain level on a scale from 0 to 10, where 0 is "no pain" and 10 is "severe pain".
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total procedural time.
Time Frame: Baseline
Total procedural time consumed starting from application of topical antiseptic up to the end of the procedure.
Baseline
Patient convenience.
Time Frame: Baseline
Patient convenience on a scale from "0" to "10", where "0" is highly convenient and "10" extremely intolerable.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 24, 2019

Primary Completion (Actual)

April 7, 2021

Study Completion (Actual)

October 11, 2021

Study Registration Dates

First Submitted

March 11, 2022

First Submitted That Met QC Criteria

March 11, 2022

First Posted (Actual)

March 21, 2022

Study Record Updates

Last Update Posted (Actual)

March 31, 2022

Last Update Submitted That Met QC Criteria

March 18, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • CG-HA-TMJ-inj.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on TMD

Clinical Trials on TMJ injection

Subscribe